Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China

Archives of Virology

Volumn 157, Issue 5, 2012, Pages 845-853

  Wu, Guocai ^a   Wang, Yun ^a   Chao, Yan ^b   Jia, Yuping ^c   Zhao, Chengquan ^d   Luo, Bing ^a  

^a QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^b GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^c WEIFANG PEOPLE'S HOSPITAL   (China)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EBNA 3C, EPSTEIN BARR VIRUS; EBNA-3C, EPSTEIN-BARR VIRUS; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CARCINOMA; CHEMISTRY; CHINA; CLASSIFICATION; EPSTEIN BARR VIRUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; JAPAN; METABOLISM; MOLECULAR GENETICS; NASOPHARYNX TUMOR; PHYLOGENY; SEQUENCE ALIGNMENT; STOMACH TUMOR; VIROLOGY;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; CARCINOMA; CHINA; GENETIC VARIATION; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT; STOMACH NEOPLASMS;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 4 TYPE 1;

EID: 84862797470     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1241-y     Document Type: Article

References (54)

1. Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I (1999) Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 91(16): 1376-1381.
2. Imai S, Nishikawa J, Takada K (1998) Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72(5): 4371-4378.
3. Brickell PM, Patel MS (1995) Epstein-Barr virus replication studies and their application to vector design. Mol Biotechnol 3(3): 199-205. doi: 10. 1007/BF02789330.
4. Yanai H, Takada K, Shimizu N, Mizugaki Y, Tada M, Okita K (1997) Epstein-Barr virus infection in non-carcinomatous gastric epithelium. J Pathol 183(3): 293-298. doi: 10. 1002/(SICI)1096-9896(199711)183: 3 <293: AID-PATH937> 3. 0. CO; 2-C.
5. Smith P (2001) Epstein-Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. Semin Cancer Biol 11(6): 469-476. doi: 10. 1006/scbi. 2001. 0414.
6. Cohen JI, Wang F, Mannick J, Kieff E (1989) Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc Natl Acad Sci USA 86(23): 9558-9562.
7. Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67(4): 2014-2025.
8. Hammerschmidt W, Sugden B, Baichwal VR (1989) The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J Virol 63(6): 2469-2475.
9. Knight JS, Lan K, Subramanian C, Robertson ES (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77(7): 4261-4272.
10. Rosendorff A, Illanes D, David G, Lin J, Kieff E, Johannsen E (2004) EBNA3C coactivation with EBNA2 requires a SUMO homology domain. J Virol 78(1): 367-377.
11. Subramanian C, Cotter MA 2nd, Robertson ES (2001) Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 7(3): 350-355. doi: 10. 1038/85499.
12. Marshall D, Sample C (1995) Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J Virol 69(6): 3624-3630.
13. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E (1995) Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J Virol 69(5): 3108-3116.
14. Allday MJ, Crawford DH, Thomas JA (1993) Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells. J Gen Virol 74(Pt 3): 361-369.
15. Petti L, Sample J, Wang F, Kieff E (1988) A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes. J Virol 62(4): 1330-1338.
16. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E (1990) Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 64(5): 2309-2318.
17. Bohnsack JF, Cooper NR (1988) CR2 ligands modulate human B cell activation. J Immunol 141(8): 2569-2576.
18. Allday MJ, Farrell PJ (1994) Epstein-Barr virus nuclear antigen EBNA3C/6 expression maintains the level of latent membrane protein 1 in G1-arrested cells. J Virol 68(6): 3491-3498.
19. Le Roux A, Kerdiles B, Walls D, Dedieu JF, Perricaudet M (1994) The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205(2): 596-602. doi: 10. 1006/viro. 1994. 1687.
20. Krauer KG, Kienzle N, Young DB, Sculley TB (1996) Epstein-Barr nuclear antigen-3 and -4 interact with RBP-2 N, a major isoform of RBP-J kappa in B lymphocytes. Virology 226(2): 346-353. doi: 10. 1006/viro. 1996. 0662.
21. Robertson ES, Lin J, Kieff E (1996) The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa). J Virol 70(5): 3068-3074.
22. Waltzer L, Perricaudet M, Sergeant A, Manet E (1996) Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 70(9): 5909-5915.
23. Zhao B, Marshall DR, Sample CE (1996) A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jkappa. J Virol 70(7): 4228-4236.
24. Radkov SA, Touitou R, Brehm A, Rowe M, West M, Kouzarides T, Allday MJ (1999) Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol 73(7): 5688-5697.
25. Touitou R, Hickabottom M, Parker G, Crook T, Allday MJ (2001) Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J Virol 75(16): 7749-7755. doi: 10. 1128/JVI. 75. 16. 7749-7755. 2001.
26. West MJ, Webb HM, Sinclair AJ, Woolfson DN (2004) Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C. J Virol 78(17): 9431-9445. doi: 10. 1128/JVI. 78. 17. 9431-9445. 2004.
27. Zhao B, Sample CE (2000) Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. J Virol 74(11): 5151-5160.
28. Subramanian C, Knight JS, Robertson ES (2002) The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration. Front Biosci 7: d704-d716.
29. Tao Q, Yang J, Huang H, Swinnen LJ, Ambinder RF (2002) Conservation of Epstein-Barr virus cytotoxic T-cell epitopes in posttransplant lymphomas: implications for immune therapy. Am J Pathol 160(5): 1839-1845. doi: 10. 1016/S0002-9440(10)61130-3.
30. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ (1992) Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176(1): 169-176.
31. Rooney CM, Smith CA, Ng CY, Loftin SK, Sixbey JW, Gan Y, Srivastava DK, Bowman LC, Krance RA, Brenner MK, Heslop HE (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92(5): 1549-1555.
32. Dawson CW, Eliopoulos AG, Blake SM, Barker R, Young LS (2000) Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells. Virology 272(1): 204-217. doi: 10. 1006/viro. 2000. 0344.
33. Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M (2001) Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J Virol 75(19): 9129-9141. doi: 10. 1128/JVI. 75. 19. 9129-9141. 2001.
34. Gutierrez MI, Raj A, Spangler G, Sharma A, Hussain A, Judde JG, Tsao SW, Yuen PW, Joab I, Magrath IT, Bhatia K (1997) Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells. J Gen Virol 78(Pt 7): 1663-1670.
35. Mai SJ, Ooka T, Li DJ, Zeng MS, Jiang RC, Yu XJ, Zhang RH, Chen SP, Zeng YX (2007) Functional advantage of NPC-related V-val subtype of Epstein-Barr virus nuclear antigen 1 compared with prototype in epithelial cell line. Oncol Rep 17(1): 141-146.
36. Midgley RS, Bell AI, McGeoch DJ, Rickinson AB (2003) Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol 77(21): 11517-11530.
37. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A (1990) Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64(9): 4084-4092.
38. Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB (1987) New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68(Pt 11): 2853-2862.
39. Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U et al (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology 154(1): 56-66.
40. Zhou XG, Sandvej K, Li PJ, Ji XL, Yan QH, Zhang XP, Da JP, Hamilton-Dutoit SJ (2001) Epstein-Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J Gen Virol 82(Pt 5): 1157-1167.
41. Cui Y, Wang Y, Liu X, Chao Y, Xing X, Zhao C, Liu C, Luo B (2011) Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Northern China. Intervirology 54(3): 131-138. doi: 10. 1159/000319632.
42. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T (1996) Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br J Cancer 74(4): 625-631.
43. Zeng MS, Li DJ, Liu QL, Song LB, Li MZ, Zhang RH, Yu XJ, Wang HM, Ernberg I, Zeng YX (2005) Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient. J Virol 79(24): 15323-15330. doi: 10. 1128/JVI. 79. 24. 15323-15330. 2005.
44. Rickinson AB, Moss DJ (1997) Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15: 405-431. doi: 10. 1146/annurev. immunol. 15. 1. 405.
45. Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ (2011) Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family. J Gen Virol 92(Pt 5): 1032-1043. doi: 10. 1099/vir. 0. 030023-0.
46. Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B (2010) Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res 147(2): 258-264. doi: 10. 1016/j. virusres. 2009. 11. 010.
47. Hu LF, Qiu QH, Fu SM, Sun D, Magnusson K, He B, Lindblom A, Ernberg I (2008) A genome-wide scan suggests a susceptibility locus on 5p 13 for nasopharyngeal carcinoma. Eur J Hum Genet 16(3): 343-349. doi: 10. 1038/sj. ejhg. 5201951.
48. Xiong W, Zeng ZY, Xia JH, Xia K, Shen SR, Li XL, Hu DX, Tan C, Xiang JJ, Zhou J, Deng H, Fan SQ, Li WF, Wang R, Zhou M, Zhu SG, Lu HB, Qian J, Zhang BC, Wang JR, Ma J, Xiao BY, Huang H, Zhang QH, Zhou YH, Luo XM, Zhou HD, Yang YX, Dai HP, Feng GY, Pan Q, Wu LQ, He L, Li GY (2004) A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64(6): 1972-1974.
49. Guo X, Johnson RC, Deng H, Liao J, Guan L, Nelson GW, Tang M, Zheng Y, de The G, O'Brien SJ, Winkler CA, Zeng Y (2009) Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 124(12): 2942-2947. doi: 10. 1002/ijc. 24293.
50. Feinberg AP (2007) Phenotypic plasticity and the epigenetics of human disease. Nature 447(7143): 433-440. doi: 10. 1038/nature05919.
51. Mill J, Tang T, Kaminsky Z, Khare T, Yazdanpanah S, Bouchard L, Jia P, Assadzadeh A, Flanagan J, Schumacher A, Wang SC, Petronis A (2008) Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 82(3): 696-711. doi: 10. 1016/j. ajhg. 2008. 01. 008.
52. Gorzer I, Niesters HG, Cornelissen JJ, Puchhammer-Stockl E (2006) Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes. Virus Res 118(1-2): 105-114. doi: 10. 1016/j. virusres. 2005. 11. 020.
53. Subramanian C, Robertson ES (2002) The metastatic suppressor Nm23-H1 interacts with EBNA3C at sequences located between the glutamine- and proline-rich domains and can cooperate in activation of transcription. J Virol 76(17): 8702-8709.
54. Chinnadurai G (2002) CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol Cell 9(2): 213-224. pii: S1097276502004434.